Investigators evaluated a deep learning model’s ability to identify ocular surface squamous neoplasia using optical coherence ...

Hyderabad: A novel and ground-breaking surgical technique developed by eye researchers from Hyderabad-based L V Prasad Eye Institute (LVPEI), involving the application of stem cells to repair the ...

Neuropathic corneal pain is a debilitating condition characterized by persistent, severe eye pain caused by nerve damage, impacting a significant number of patients worldwide. OKYO Pharma's urcosimod ...

Tis means some of the cells within the lining of the anus have abnormal changes. Doctors call this anal intraepithelial neoplasia (AIN) 2-3. Or a high-grade squamous intraepithelial lesion (HSIL). You ...

1Department of Otolaryngology—Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota. 2Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Such areas may resemble or be at higher risk for oral squamous cell carcinoma (SCC). Without routine biopsies, occult SCC may remain undiagnosed. Objectives: This study investigated the prevalence and ...

An abnormal Pap smear result of high-grade squamous intraepithelial lesion (HSIL ... HSIL is also called moderate or severe dysplasia or cervical intraepithelial neoplasia (CIN 2 or CIN 3). Treatment ...

For example, human papillomavirus (HPV) infection is the underlying cause of up to half of squamous cell cancer of the vulva. Changes to the vulvar skin from HPV, lichen sclerosus, or chronic vulvar ...

Jasmin Bhasin recently opened up about the extent of the corneal damage she suffered in July 2024, while also sharing the turn of events that led to the fateful incident. “Shukr karo sab theek hai ...

The first corneal transplant surgeries to take place in Newfoundland and Labrador in decades occurred this week in St. John’s and the surgeon who performed them is crediting VOCM Open Line for helping ...

Following the success of Akeso’s HARMONi-2 study in China where the PFS benefit was observed in a monotherapy setting for patients whose squamous or non-squamous tumors were positive for PD-L1 ...

In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed tislelizumab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.